Physician profile
Deborah K Phillips
NPI 1124002811
$2,425.81
in general payments reported to CMS, 2019-2025
14 companies · $74.58 in 2025
The $74.58 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,272 · 2020: $51.88 · 2021: $122 · 2022: $211 · 2023: $361 · 2024: $334 · 2025: $74.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $684 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $684.14 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $746.27 | 2019-2022 | |
| Abbvie INC. | $474.47 | 2019-2024 | |
| Galderma Laboratories, L.P. | $297.93 | 2019-2023 | Dysport |
| Pfizer INC. | $189.82 | 2019-2023 | |
| Arcutis Biotherapeutics, INC. | $169.01 | 2024-2025 | Zoryve |
| Janssen Biotech, INC. | $160.21 | 2019-2024 | Tremfya |
| Revance Therapeutics, INC. | $137.44 | 2024 | Daxxify |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $123.42 | 2019 | |
| Novartis Pharmaceuticals Corporation | $38.55 | 2019 | |
| Vyne Pharmaceuticals INC. | $22.03 | 2021 | |
| Allergan, INC. | $21.00 | 2020 | |
| Genzyme Corporation | $19.27 | 2019 | |
| Epi Health, LLC | $13.59 | 2019 | |
| Leo Pharma INC. | $12.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.